Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001387131-22-008886

Co-CEO & President bought 5,809,132 shares at $0.97 ($5,634,858)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Maky · Co-CEO & President

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-16 Purchase : show line 1 in the form +184,430 $0.97 $178,897 359,969 D
2022-08-16 Purchase : show line 2 in the form +4,593,777 $0.97 $4,455,964 7,061,557 I
2022-08-16 Purchase : show line 3 in the form +1,030,925 $0.97 $999,997 3,135,466 I
Open-market purchases · 5,809,132 sh · avg $0.97 · $5,634,858
Loading xslF345X03/zangeneh-form4_081622.xml…